SCHEMBL2890734

SCHEMBL2890734

O=C(Nc1ccc(Br)cn1)c1ccc(F)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.68
NPC1 O15118 8/20 0.66
RAB9A P51151 7/20 0.66
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
RXFP1 Q9HBX9 2/20 0.66
RECQL P46063 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
TP53 P04637 1/20 0.54
MAPK1 P28482 1/20 0.54
CASP3 P42574 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
HCAR3 P49019 1/20 0.53
LMNA P02545 1/20 0.52
DEGS1 O15121 1/20 0.51
PTGS1 P23219 2/20 0.50
TSHR P16473 1/20 0.50
KCNQ3 O43525 1/20 0.50
KCNQ2 O43526 1/20 0.50
KCNE1 P15382 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20177030 0.91 KDM4E (0.64) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL24891928 0.86 NPC1 (0.68) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL31241065 0.84 RAB9A (0.79) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL1558817 0.84 RAB9A (0.79) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL24669456 0.82 NPC1 (0.68) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL29803410 0.82 NPC1 (0.68) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL30182773 0.82 RAB9A (0.62) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL24891679 0.82 RAB9A (0.62) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL25383854 0.81 PTGS1 (0.74) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL3500869 0.81 NPC1 (0.66) KDM4ENPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS RANBAXY LABORATORIES LIMITED (IN) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286211-A1 OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS OXA1L, PDK4, MLYCD KDM4E 2731/4885NPC1 3916/4885RAB9A 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.